Obesity: open trials in Canada

86 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT06897475
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Trial Treatment · Phase 2 · Eli Lilly and Company
Centricity Research Brampton Endocrinology, Brampton · Ecogene-21, Chicoutimi · Winterberry Research Inc., Hamilton · Viacar Recherche Clinique, Longueuil · G A Research Associates, Moncton · Bluewater Clinical Research Group Inc., Sarnia · Maple Leaf Research, Toronto · Diabetes Heart Research Centre, Toronto · Fadia El Boreky Medicine, Waterloo
Registry updated 2026-11-04
NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
London Digestive Disease Institute, London · London Health Sciences Centre, London · Clinique IMD, Montreal · The Ottawa Hospital - General Campus, Ottawa · (G.I.R.I.) GI Research Institute Foundation, Vancouver · Vancouver General Hospital, Vancouver
Registry updated 2026-11-04
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Gastroenterology and internal medicine research institute, Edmonton · London Digestive Disease Institute, London · London Health Sciences Centre, London · Clinique IMD, Montreal · The Ottawa Hospital - General Campus, Ottawa · (G.I.R.I.) GI Research Institute Foundation, Vancouver · Vancouver General Hospital, Vancouver
Registry updated 2026-11-04
NCT07202884
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
OCT Research ULC, Kelowna · Kelowna Health and Memory Centre, Kelowna · Alpha Recherche Clinique - Lévis, Lévis · The Fe/Male Health Centre, Oakville · Alpha Recherche Clinique, Québec · CaRe Clinic, Red Deer · Sunnybrook Research Institute, Toronto
Registry updated 2026-11-04
NCT07353931
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Apex Trials, Guelph · G.R.M.O. (Groupe de recherche en maladies osseuses) Inc., Québec · Diex Recherche Inc. Division Quebec, Québec · Stouffville Medical Research Institute Inc., Stouffville · Dr. Anil K. Gupta Medicine Professional Corporation, Toronto · Maple Leaf Research, Toronto · Diex Recherche Inc. Division Victoriaville, Victoriaville
Registry updated 2026-11-04
NCT07369011
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
MyCliniResearch, Inc., Calgary · Alpha Recherche Clinique - Lévis, Lévis · Alpha Recherche Clinique, Québec · C.I.C. Saint-Laurent, Saint-Laurent · Maple Leaf Research, Toronto · C.I.C. Mauricie inc., Trois-Rivières
Registry updated 2026-11-04
NCT07668661
OBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders
Trial Treatment · CHU de Quebec-Universite Laval
CHU de Quebec-Universite Laval, Québec
Registry updated 2026-11-03
NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Trial Treatment · Phase 3 · Eli Lilly and Company
Well Health Diagnostic Center- Brampton Center, Brampton · Centricity Research Brampton Endocrinology, Brampton · C-health Research, Calgary · NSHA-QEII Health Sciences Centre-Dickson Bldg, Halifax · Kelowna Health and Memory Centre, Kelowna · Endocrinologie Oasis, Montreal · Centricity Research Pointe-Claire Multispecialty, Pointe-Claire · IUCPQ, Québec · NL Health Services, St. John's · Centre de Medecine Metabolique de Lanaudiere (CMML), Terrebonne · Clinical Research Solutions - Kitchener, Waterloo
Registry updated 2026-11-03
NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Trial Treatment · Phase 3 · Amgen
Brampton Clinical Trials, Brampton · Cambridge Cardiac Care Centre, Cambridge · Saul Vizel Professional Medicine Corporation - Vizel Cardiac Research, Cambridge · Ecogene-21, Chicoutimi · University of Alberta Hospital, Edmonton · Montreal Heart Institute, Montreal · Partners in Advanced Cardiac Evaluation, Newmarket · North York Diagnostic and Cardiac Centre, North York · Kawartha Cardiology Clinical Trials, Peterborough · CardioQuest Research Centre, Sarnia · Heart Health Institute Research Incorporated, Scarborough Village · Diex Recherche Sherbrooke Est, Sherbrooke · KMH Cardiology Centres Incorporated Hamilton, Stoney Creek · Curans Heart Center, Thunder Bay · Diabetes Heart Research Centre, Toronto · Womens College Hospital, Toronto · Diex Recherche Trois-Rivieres, Trois-Rivières · CPS Research, Waterloo · Winchester District Memorial Hospital, Winchester · St. Boniface Hospital, Winnipeg · Cardio 1, Winnipeg
Registry updated 2026-10-29
NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Trial Treatment · Phase 3 · AstraZeneca
Calgary · Hamilton · Joliette · Markham · Moncton · Montreal · North York · Québec · Sarnia · Scarborough Village · Stoney Creek · Stouffville · Toronto · Trois-Rivières · Truro · Vancouver
Registry updated 2026-10-28
NCT07900074
Mechanisms of Weight Loss: Tirzepatide vs Semaglutide
Trial Treatment · Phase 4 · McMaster University
McMaster University, Hamilton
Registry updated 2026-10-28
NCT06555393
Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study
Trial Treatment · Phase 1 · University of Alberta
University of Alberta, Edmonton
Registry updated 2026-10-26
NCT07592546
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
Trial Treatment · Phase 4 · Alain Dagher
The Montreal Neurological Institute-Hospital, Montreal
Registry updated 2026-10-26
NCT04578652
Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance
Trial Treatment · Phase 3 · University of Alberta
University of Alberta, Edmonton
Registry updated 2026-10-23
NCT07891156
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
Trial Treatment · Phase 2/3 · McGill University Health Centre/Research Institute of the McGill University Health Centre
Research Institute of the McGill University Health Centre Royal Victoria Hospital, Montreal
Registry updated 2026-10-23
NCT07624071
A Study to Evaluate ALN-6222 in Participants With Obesity
Trial Treatment · Phase 1 · Alnylam Pharmaceuticals
Mount Royal
Registry updated 2026-10-21
NCT07130838
EAT SMART Teen Study
Trial Treatment · Gary Goldfield
Children'S Hospital Of Eastern Ontario, Ottawa
Registry updated 2026-10-20
NCT07463846
A Study to Evaluate ALN-2232 in Participants With Obesity
Trial Treatment · Phase 1/2 · Alnylam Pharmaceuticals
Mount Royal
Registry updated 2026-10-13
NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Trial Treatment · Phase 3 · AstraZeneca
Brampton · Calgary · Hamilton · Joliette · Moncton · Montreal · Niagara Falls · North York · Saint-Lambert · Sarnia · Scarborough Village · Stouffville · Terrebonne · Toronto · Truro · Vancouver · Victoria
Registry updated 2026-10-13
NCT07575438
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults
Trial Treatment · Phase 2 · May Faraj, PDt, PhD
Institut de Recherches Cliniques de Montréal (IRCM), Montreal
Registry updated 2026-10-08
NCT07187830
Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
Research · University of Alberta
Mazankowski Alberta Heart Institute, Edmonton
Registry updated 2026-10-07
NCT07684144
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Trial Treatment · Phase 3 · Amgen
Hamilton Medical Research Group, Hamilton
Registry updated 2026-10-05
NCT07684235
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Trial Treatment · Phase 3 · Amgen
Ecogene-21, Chicoutimi · Wharton Medical Clinic, Hamilton · Curans Heart Center, Thunder Bay
Registry updated 2026-10-05
NCT07858331
Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
Trial Treatment · Phase 4 · Kristin Clemens
London Health Sciences Centre, London · St. Joseph's Health Care, London
Registry updated 2026-10-05
NCT07363148
A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults
Trial Treatment · Arrae
KGK Science Inc., London
Registry updated 2026-09-30

All Obesity trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error